Chiesi Farmaceutici SpA - Strategic SWOT Analysis Review

Chiesi Farmaceutici SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the companys key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy summarization of the companys business strategy.
- SWOT analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list of key locations and subsidiaries of the company, including contact details.

Highlights

Chiesi Farmaceutici SpA (Chiesi) researches, develops, produces and commercializes novel medicines with focus on respiratory, neonatology, rare disease and special care therapeutic areas. The company provides products for the treatment of chronic obstructive pulmonary disease (COPD), asthma, rheumatoid arthritis, ankylosing spondylitis, hypertension, percutaneous coronary intervention, apnoea of prematurity, respiratory distress syndrome, lipoprotein lipase deficiency (LPLD), limbal stem cell deficiency (LSCD) and inflammatory bowel diseases, among others. The company operates production sites in Parma, Italy; Blois, France; and Santana De Parnaiba, Brazil; and conducts research and development activities at its R&D center in Parma and at laboratories in Paris, Chippenham (the UK), Cary (the US) and Lidingo (Sweden. Chiesi is headquartered in Parma, Italy.

Chiesi Farmaceutici SpA Key Recent Developments

Apr 08,2020: Chiesi Group increases support measures and announces new funds for employees, patients and, healthcare providers in response to COVID-19 pandemic
Feb 07,2020: Chiesi forms new rare diseases business unit
Aug 05,2019: Santhera licences Lebers hereditary optic neuropathy drug to Chiesi
Jul 09,2019: Chiesi Group confirms positive trend to date for 2019
Jun 06,2019: Chiesi Group is the largest pharmaceutical group in the world to be awarded B Corp certification

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this reports analysis of the companys business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors business structure and strategies with detailed SWOT analysis. In this, the companys core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this reports detailed insight into the companys strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.



Section 1 - About the Company
Chiesi Farmaceutici SpA - Key Facts
Chiesi Farmaceutici SpA - Key Employees
Chiesi Farmaceutici SpA - Major Products and Services
Chiesi Farmaceutici SpA - History
Chiesi Farmaceutici SpA - Company Statement
Chiesi Farmaceutici SpA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 Company Analysis
Company Overview
Chiesi Farmaceutici SpA - Business Description
Chiesi Farmaceutici SpA - SWOT Analysis
SWOT Analysis - Overview
Chiesi Farmaceutici SpA - Strengths
Chiesi Farmaceutici SpA - Weaknesses
Chiesi Farmaceutici SpA - Opportunities
Chiesi Farmaceutici SpA - Threats
Chiesi Farmaceutici SpA - Key Competitors
Section 3 Companys Lifesciences Financial Deals and Alliances
Chiesi Farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Chiesi Farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Chiesi Farmaceutici SpA, Recent Deals Summary
Section 4 Companys Recent Developments
Apr 08, 2020: Chiesi Group increases support measures and announces new funds for employees, patients and, healthcare providers in response to COVID-19 pandemic
Feb 07, 2020: Chiesi forms new rare diseases business unit
Aug 05, 2019: Santhera licences Lebers hereditary optic neuropathy drug to Chiesi
Jul 09, 2019: Chiesi Group confirms positive trend to date for 2019
Jun 06, 2019: Chiesi Group is the largest pharmaceutical group in the world to be awarded B Corp certification
Section 5 Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables


Chiesi Farmaceutici SpA, Key Facts
Chiesi Farmaceutici SpA, Key Employees
Chiesi Farmaceutici SpA, Major Products and Services
Chiesi Farmaceutici SpA, History
Chiesi Farmaceutici SpA, Subsidiaries
Chiesi Farmaceutici SpA, Joint Venture
Chiesi Farmaceutici SpA, Key Competitors
Chiesi Farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Chiesi Farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Chiesi Farmaceutici SpA, Recent Deals Summary

List Of Figures


Chiesi Farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Chiesi Farmaceutici SpA, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

Chiesi Farmaceutici S. P. A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Chiesi Farmaceutici S. P. A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportMarketlines Chiesi Farmaceutici S. P. A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments

USD 350 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available